Best Health Care Sector Stocks to Invest in Today
Discover the top-performing companies in the health care sector that combine strong returns with positive social impact. Explore 100 carefully selected stocks with real-time data and ESG ratings.
Data updated in real-time • 100 stocks analyzed • ESG ratings included
Health Care Sector Overview
Healthcare providers, pharmaceutical companies, medical device manufacturers, and biotechnology firms focused on patient access, safety, and sustainable healthcare innovation.
Sector Statistics
Market Outlook
Growth driven by aging demographics, healthcare innovation, digital transformation, focus on preventive medicine, and increasing emphasis on equitable healthcare access and sustainability.
Industry Overview
Healthcare sector encompasses companies providing medical services, developing pharmaceuticals, manufacturing medical devices, and advancing biotechnology solutions to improve human health with focus on accessibility and ethical practices.
Key Trends & Opportunities
Personalized medicine, telemedicine, digital health, gene therapy, preventive care, healthcare accessibility, clinical trial diversity, and sustainable pharmaceutical development.
ESG Focus Areas
Patient access to healthcare, drug pricing transparency, clinical trial diversity, healthcare worker safety, environmental impact reduction, ethical research practices, and community health initiatives.
Top Performers
Johnson & Johnson (JNJ), Pfizer (PFE), UnitedHealth Group (UNH), Merck (MRK), and AbbVie (ABBV) leading in patient access and sustainability.
Sustainability Leaders
Companies prioritizing global health access, sustainable pharmaceutical practices, diverse clinical trials, and transparent health outcome reporting.
Top Health Care Sector Stock Picks Today
Interactive table showing the best-performing stocks with ESG ratings and key financial metrics
Showing 1 to 20 of 100 stocks
Page 1 of 5
Company | Price | Votes | Market Cap | ESG Rating | Action |
|---|---|---|---|---|---|
| $28.94 | 0 | $1.2B | 37.8 (E:N/A S:N/A G:N/A) | View Details → | |
AbbVie Inc. ABBV | $40.19 | 0 | $1.1B | 60/100 | View Details → |
| $242.28 | 0 | $9.2B | 65/100 | View Details → | |
| $329.16 | 0 | $15.8B | 87/100 | View Details → | |
| $411.18 | 0 | $19.5B | 74.7/100 | View Details → | |
Amgen Inc. AMGN | $45.16 | 0 | $1.1B | 81/100 | View Details → |
Anthem, Inc. ANTM | $210.45 | 0 | $4.0B | 69/100 | View Details → |
| $34.24 | 0 | $1.7B | N/A | View Details → | |
| $76.50 | 0 | $19.6B | 86/100 | View Details → | |
| $179.86 | 0 | $4.9B | 24.0 (E:N/A S:N/A G:N/A) | View Details → | |
Avantor, Inc. AVTR | $408.40 | 0 | $19.9B | 15.8 (Low Risk) | View Details → |
| $419.73 | 0 | $17.4B | N/A | View Details → | |
| $54.79 | 0 | $1.5B | 74.4/100 | View Details → | |
Bayer B10 | $18.50 | 0 | $74.1M | 26/100 | View Details → |
| $360.45 | 0 | $5.6B | 70/100 | View Details → | |
| $115.67 | 0 | $5.3B | 53.5/100 | View Details → | |
Biogen B11 | $347.64 | 0 | $6.2B | 71/100 | View Details → |
| $427.43 | 0 | $11.2B | 26/100 | View Details → | |
| $85.08 | 0 | $4.0B | 79/100 | View Details → | |
| $117.20 | 0 | $3.6B | 66/100 | View Details → |